National Research Corporation

Symbol: NRC

NASDAQ

39.61

USD

Market price today

  • 22.6846

    P/E Ratio

  • -4.9906

    PEG Ratio

  • 944.87M

    MRK Cap

  • 0.05%

    DIV Yield

National Research Corporation (NRC) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.61%

Operating Profit Margin

0.27%

Net Profit Margin

0.21%

Return on Assets

0.25%

Return on Equity

0.48%

Return on Capital Employed

0.46%

Company general description and statistics

Sector: Healthcare
Industry: Healthcare - Information Services
CEO:Mr. Michael D. Hays
Full-time employees:435
City:Lincoln
Address:1245 Q Street
IPO:2013-05-23
CIK:0000070487

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

General Outlook

When we look at how much money they make before expenses, they keep 0.613% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.270%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.208%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.253% return, is a testament to National Research Corporation's adeptness in optimizing resource deployment. National Research Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.478%. Furthermore, the proficiency of National Research Corporation in capital utilization is underscored by a remarkable 0.464% return on capital employed.

Stock Prices

National Research Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $34.86, while its low point bottomed out at $33.78. This variance in figures offers investors a lucid insight into the roller-coaster ride that is National Research Corporation's stock market.

Liquidity Ratios

Analyzing NRC liquidity ratios reveals its financial health of the firm. The current ratio of 67.29% gauges short-term asset coverage for liabilities. The quick ratio (53.24%) assesses immediate liquidity, while the cash ratio (18.38%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio67.29%
Quick Ratio53.24%
Cash Ratio18.38%

Profitability Ratios

NRC profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 26.90% underscores its earnings before tax deductions. The effective tax rate stands at 22.50%, revealing its tax efficiency. The net income per EBT, 77.50%, and the EBT per EBIT, 99.79%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 26.95%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin26.90%
Effective Tax Rate22.50%
Net Income per EBT77.50%
EBT per EBIT99.79%
EBIT per Revenue26.95%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.67, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding53
Operating Cycle31.01
Days of Payables Outstanding8
Cash Conversion Cycle23
Receivables Turnover11.77
Payables Turnover44.15
Fixed Asset Turnover4.91
Asset Turnover1.21

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.56, and free cash flow per share, 0.91, depict cash generation on a per-share basis. The cash per share value, 0.27, showcases liquidity position. A payout ratio of 1.17 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.26, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share1.56
Free Cash Flow per Share0.91
Cash per Share0.27
Payout Ratio1.17
Operating Cash Flow Sales Ratio0.26
Free Cash Flow to Operating Cash Flow Ratio0.59
Cash Flow Coverage Ratio1.02
Short Term Coverage Ratio4.88
Capital Expenditure Coverage Ratio2.42
Dividend Paid and Capex Coverage Ratio0.73
Dividend Payout Ratio0.04

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 30.45%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.76, we discern the balance between debt and equity financing. The long-term debt to capitalization, 37.58%, and total debt to capitalization, 43.24%, ratios shed light on its capital structure. An interest coverage of 46.46 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio30.45%
Debt Equity Ratio0.76
Long Term Debt to Capitalization37.58%
Total Debt to Capitalization43.24%
Interest Coverage46.46
Cash Flow to Debt Ratio1.02
Company Equity Multiplier2.50

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 6.05, provides a glimpse into top-line earnings distributed across each share. Net income per share, 1.26, reflects the portion of profit attributed to each share. The book value per share, 1.99, represents the net asset value distributed per share, while the tangible book value per share, -0.58, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share6.05
Net Income Per Share1.26
Book Value Per Share1.99
Tangible Book Value Per Share-0.58
Shareholders Equity Per Share1.99
Interest Debt Per Share1.58
Capex Per Share-0.64

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -1.97%, indicates top-line expansion, while the gross profit growth, -8.31%, reveals profitability trends. EBIT growth, -13.87%, and operating income growth, -13.87%, offer insights into operational profitability progression. The net income growth, -2.61%, showcases bottom-line expansion, and the EPS growth, -1.56%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-1.97%
Gross Profit Growth-8.31%
EBIT Growth-13.87%
Operating Income Growth-13.87%
Net Income Growth-2.61%
EPS Growth-1.56%
EPS Diluted Growth-1.57%
Weighted Average Shares Growth-1.53%
Weighted Average Shares Diluted Growth-1.51%
Dividends per Share Growth76.19%
Operating Cash Flow Growth5.10%
Free Cash Flow Growth-15.50%
10-Year Revenue Growth per Share57.75%
5-Year Revenue Growth per Share37.04%
3-Year Revenue Growth per Share14.34%
10-Year Operating CF Growth per Share93.98%
5-Year Operating CF Growth per Share5.58%
3-Year Operating CF Growth per Share-3.80%
10-Year Net Income Growth per Share96.63%
5-Year Net Income Growth per Share13.78%
3-Year Net Income Growth per Share-14.74%
10-Year Shareholders Equity Growth per Share-32.93%
5-Year Shareholders Equity Growth per Share183.18%
3-Year Shareholders Equity Growth per Share-21.93%
10-Year Dividend per Share Growth per Share1568.98%
5-Year Dividend per Share Growth per Share138.11%
3-Year Dividend per Share Growth per Share254.66%
Receivables Growth-12.71%
Asset Growth-6.15%
Book Value per Share Growth-30.98%
Debt Growth75.63%
SGA Expenses Growth9.09%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,003,105,400, captures the company's total value, considering both debt and equity. Income quality, 1.23, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 51.52%, indicates the value of non-physical assets, and capex to operating cash flow, -41.40%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value1,003,105,400
Income Quality1.23
Intangibles to Total Assets51.52%
Capex to Operating Cash Flow-41.40%
Capex to Revenue-10.62%
Capex to Depreciation-267.49%
Stock-Based Compensation to Revenue0.63%
Graham Number7.53
Return on Tangible Assets52.18%
Graham Net Net-2.34
Working Capital-11,843,000
Tangible Asset Value-14,130,000
Net Current Asset Value-49,122,000
Invested Capital1
Average Receivables13,542,000
Average Payables3,218,500
Days Sales Outstanding31
Days Payables Outstanding8
ROIC36.02%
ROE0.63%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 14.35, and the price to book ratio, 14.35, reflect the market's valuation relative to the company's book value. The price to sales ratio, 4.62, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 30.71, and price to operating cash flows, 18.43, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio14.35
Price to Book Ratio14.35
Price to Sales Ratio4.62
Price Cash Flow Ratio18.43
Price Earnings to Growth Ratio-4.99
Enterprise Value Multiple14.00
Price Fair Value14.35
Price to Operating Cash Flow Ratio18.43
Price to Free Cash Flows Ratio30.71
Price to Tangible Book Ratio19.83
Enterprise Value to Sales6.75
Enterprise Value Over EBITDA21.81
EV to Operating Cash Flow26.32
Earnings Yield3.19%
Free Cash Flow Yield2.30%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of National Research Corporation (NRC) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 22.685 in 2024.

What is the ticker symbol of National Research Corporation stock?

The ticker symbol of National Research Corporation stock is NRC.

What is company IPO date?

IPO date of National Research Corporation is 2013-05-23.

What is company current share price?

Current share price is 39.610 USD.

What is stock market cap today?

The market cap of stock today is 944872784.000.

What is PEG ratio in 2024?

The current -4.991 is -4.991 in 2024.

What is the number of employees in 2024?

In 2024 the company has 435.